http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100628284-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
filingDate 1999-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100628284-B1
titleOfInvention Benzamide Derivatives for the Treatment of Cytokine-mediated Diseases
abstract The present invention is directed to the treatment of diseases or medical conditions mediated by amide derivatives of formula (1) or pharmaceutically acceptable salts thereof or biodegradable esters thereof, methods for their preparation, pharmaceutical compositions containing them and cytokines It is about how to use:n n n Formula 1n n n n n n n n In the above formula,n n n R 1 and R 2 include hydroxy, C 1-6 alkoxy, mercapto, C 1-6 alkylthio, amino and heterocyclyl,n n n m and p are independently 0 to 3,n n n R 3 is halo, cyano or C 1-6 alkoxy,n n n q is 0 to 4,n n n R 4 is aryl or cycloalkyl, wherein R 4 is optionally substituted with up to 3 substituents having any value defined by each R 1 group.
priorityDate 1998-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467079345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7707

Total number of triples: 38.